Study Finds Possible Treatment to Prevent TMPRSS3 Hearing Loss
A new study has identified how electrical charges in the inner ear trigger TMPRSS3-related hearing loss—and found that a common drug may help prevent it.
A new study has identified how electrical charges in the inner ear trigger TMPRSS3-related hearing loss—and found that a common drug may help prevent it.
Amplifon has been named to Time magazine’s list of the World’s Best Companies 2025, its third consecutive year on the list.
HIA's MarkeTrak 2025 study of the U.S. hearing loss market provides new data on prescription hearing aids, OTC devices, and emerging technologies.
HearUSA has been recognized for the third year in a row on Newsweek’s America’s Best Retailers list.
The International Hearing Society has announced its 2025 Award winners, including for The Hearing Review Professional Leadership Award.
The House Veterans’ Affairs Committee considered language for the Veterans’ ACCESS Act that would expanding VA coverage to include hearing aid specialists.
Dr Melvin J. Sorkowitz a disruptor who helped make audiology what it is today, has died at 86—but his impact still echoes.
The therapy targets mutations in the CLIC5 gene, which affect hair cell stability and lead to progressive hearing and balance impairments.
Doctoral students in Audiology from across the U.S. attended the 2025 Oticon Summer Camp for real-world clinical practice and career development.